DCM
ALBO

Driehaus Capital Management’s Albireo Pharma Inc ALBO Stock Holding History

Driehaus Capital Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-13,500
Closed -$506K – 540
2020
Q4 		$506K Sell
13,500
-99,670
-88% -$3.62M 0.01% 363
2020
Q3 		$3.78M Buy
113,170
+83,170
+277% +$2.42M 0.08% 227
2020
Q2 		$795K Buy
+30,000
New +$708K 0.02% 296

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Driehaus Capital Management's ALBO Position: Q1 2021 in Review

Driehaus Capital Management sold out of Albireo Pharma Inc (ALBO) in Q1 2021, closing a stake of 13,500 shares — an estimated $506K sold.

Driehaus Capital Management first reported a position in ALBO in Q2 2020 and held it in 3 quarters. The position peaked at $3.78M in Q3 2020. 100 funds tracked by Wall St. Rank hold ALBO as of Q1 2021.

  • Driehaus Capital Management reported no remaining Albireo Pharma Inc position as of Q1 2021 after selling out during the quarter.
  • Driehaus Capital Management sold 13,500 Albireo Pharma Inc shares in Q1 2021, an estimated $506K.
  • Driehaus Capital Management first reported a position in Albireo Pharma Inc in Q2 2020 and held it in 3 quarters.
  • Driehaus Capital Management's Albireo Pharma Inc position peaked at $3.78M in Q3 2020.
  • 100 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2021.

Based on Driehaus Capital Management's 13F filing for Q1 2021, filed 17 May 2021.